Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology and seed company, today announced that the company has licensed its Persephone genome ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE